US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 4.7000
  • +0.0300+0.64%
Close Apr 18 16:00 ET
  • 4.5800
  • -0.1200-2.55%
Post 18:54 ET
127.02MMarket Cap-1587P/E (TTM)

VistaGen Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
129.06%411.4K
131.11%277.7K
-42.73%177.6K
-120.50%-227.3K
351.41%175.6K
-49.82%179.6K
-349.30%-892.5K
-12.43%310.1K
1.78%1.11M
-91.20%38.9K
Operating revenue
129.06%411.4K
131.11%277.7K
-42.73%177.6K
-120.50%-227.3K
351.41%175.6K
-49.82%179.6K
-349.30%-892.5K
-12.43%310.1K
1.78%1.11M
-91.20%38.9K
Cost of revenue
Gross profit
Operating expense
-16.59%8.3M
-57.48%7.06M
-64.27%7.18M
21.34%59.04M
-25.80%12.42M
-8.74%9.95M
26.14%16.6M
155.25%20.08M
155.76%48.66M
151.19%16.73M
Selling and administrative expenses
21.54%3.76M
-13.37%3.21M
-37.85%2.98M
10.69%14.66M
-31.57%3.08M
-0.83%3.09M
14.93%3.7M
98.76%4.79M
86.64%13.25M
93.80%4.5M
-Selling and marketing expense
----
----
-93.54%84K
-31.90%1.9M
----
----
----
1,175.49%1.3M
--2.8M
--1.37M
-General and administrative expense
21.54%3.76M
-13.37%3.21M
-17.10%2.89M
22.08%12.76M
-62.43%1.17M
36.09%3.09M
34.81%3.7M
51.19%3.49M
47.25%10.45M
34.64%3.13M
Research and development costs
-33.80%4.54M
-70.14%3.85M
-72.55%4.2M
25.33%44.38M
-23.68%9.34M
-11.90%6.85M
29.77%12.89M
180.21%15.29M
196.90%35.41M
181.88%12.23M
Operating profit
19.27%-7.88M
61.23%-6.78M
64.61%-7M
-24.65%-59.27M
26.68%-12.24M
7.34%-9.77M
-36.64%-17.49M
-163.15%-19.77M
-165.12%-47.55M
-168.41%-16.69M
Net non-operating interest income expense
28,847.17%1.53M
3,055.74%192.5K
4,750.00%97K
30.00%26K
146.00%12.3K
6.00%5.3K
22.00%6.1K
-60.00%2K
900.00%20K
-37.50%5K
Non-operating interest income
28,847.17%1.53M
3,055.74%192.5K
1,616.67%103K
145.00%49K
606.00%35.3K
6.00%5.3K
22.00%6.1K
20.00%6K
33.33%20K
-44.44%5K
Non-operating interest expense
----
----
50.00%6K
--23K
----
----
----
--4K
--0
--0
Other net income (expense)
-38,766.67%-232K
0
Special income (charges)
----
----
----
--0
----
----
----
----
---232K
--0
-Write off
----
----
----
--0
----
----
----
----
--232K
--0
Income before tax
34.95%-6.35M
62.32%-6.59M
65.10%-6.9M
-24.04%-59.24M
26.74%-12.23M
7.35%-9.76M
-36.65%-17.48M
-155.40%-19.77M
-166.34%-47.76M
-168.70%-16.69M
Income tax
0
0
-54.55%2.5K
73.53%5.9K
400
0
0
61.76%5.5K
30.77%3.4K
0
Net income
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
-155.36%-19.78M
-166.32%-47.76M
-168.70%-16.69M
Net income continuous Operations
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
-155.36%-19.78M
-166.32%-47.76M
-168.70%-16.69M
Minority interest income
Net income attributable to the parent company
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
-155.36%-19.78M
-166.32%-47.76M
-168.70%-16.69M
Preferred stock dividends
-96.12%945.1K
0
Other preferred stock dividends
Net income attributable to common stockholders
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-21.64%-59.25M
26.73%-12.23M
9.14%-9.76M
-32.75%-17.48M
-143.96%-19.78M
-15.09%-48.71M
43.54%-16.69M
Basic earnings per share
84.51%-0.22
74.02%-0.66
67.25%-0.94
-15.31%-8.5091
34.51%-1.6891
5.33%-1.42
-20.95%-2.54
-139.17%-2.87
49.80%-7.3793
47.47%-2.5793
Diluted earnings per share
84.51%-0.22
74.02%-0.66
67.25%-0.94
-15.31%-8.5091
34.51%-1.6891
5.33%-1.42
-20.95%-2.54
-139.17%-2.87
49.80%-7.3793
47.47%-2.5793
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 129.06%411.4K131.11%277.7K-42.73%177.6K-120.50%-227.3K351.41%175.6K-49.82%179.6K-349.30%-892.5K-12.43%310.1K1.78%1.11M-91.20%38.9K
Operating revenue 129.06%411.4K131.11%277.7K-42.73%177.6K-120.50%-227.3K351.41%175.6K-49.82%179.6K-349.30%-892.5K-12.43%310.1K1.78%1.11M-91.20%38.9K
Cost of revenue
Gross profit
Operating expense -16.59%8.3M-57.48%7.06M-64.27%7.18M21.34%59.04M-25.80%12.42M-8.74%9.95M26.14%16.6M155.25%20.08M155.76%48.66M151.19%16.73M
Selling and administrative expenses 21.54%3.76M-13.37%3.21M-37.85%2.98M10.69%14.66M-31.57%3.08M-0.83%3.09M14.93%3.7M98.76%4.79M86.64%13.25M93.80%4.5M
-Selling and marketing expense ---------93.54%84K-31.90%1.9M------------1,175.49%1.3M--2.8M--1.37M
-General and administrative expense 21.54%3.76M-13.37%3.21M-17.10%2.89M22.08%12.76M-62.43%1.17M36.09%3.09M34.81%3.7M51.19%3.49M47.25%10.45M34.64%3.13M
Research and development costs -33.80%4.54M-70.14%3.85M-72.55%4.2M25.33%44.38M-23.68%9.34M-11.90%6.85M29.77%12.89M180.21%15.29M196.90%35.41M181.88%12.23M
Operating profit 19.27%-7.88M61.23%-6.78M64.61%-7M-24.65%-59.27M26.68%-12.24M7.34%-9.77M-36.64%-17.49M-163.15%-19.77M-165.12%-47.55M-168.41%-16.69M
Net non-operating interest income expense 28,847.17%1.53M3,055.74%192.5K4,750.00%97K30.00%26K146.00%12.3K6.00%5.3K22.00%6.1K-60.00%2K900.00%20K-37.50%5K
Non-operating interest income 28,847.17%1.53M3,055.74%192.5K1,616.67%103K145.00%49K606.00%35.3K6.00%5.3K22.00%6.1K20.00%6K33.33%20K-44.44%5K
Non-operating interest expense --------50.00%6K--23K--------------4K--0--0
Other net income (expense) -38,766.67%-232K0
Special income (charges) --------------0-------------------232K--0
-Write off --------------0------------------232K--0
Income before tax 34.95%-6.35M62.32%-6.59M65.10%-6.9M-24.04%-59.24M26.74%-12.23M7.35%-9.76M-36.65%-17.48M-155.40%-19.77M-166.34%-47.76M-168.70%-16.69M
Income tax 00-54.55%2.5K73.53%5.9K4000061.76%5.5K30.77%3.4K0
Net income 34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M-155.36%-19.78M-166.32%-47.76M-168.70%-16.69M
Net income continuous Operations 34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M-155.36%-19.78M-166.32%-47.76M-168.70%-16.69M
Minority interest income
Net income attributable to the parent company 34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M-155.36%-19.78M-166.32%-47.76M-168.70%-16.69M
Preferred stock dividends -96.12%945.1K0
Other preferred stock dividends
Net income attributable to common stockholders 34.95%-6.35M62.32%-6.59M65.09%-6.9M-21.64%-59.25M26.73%-12.23M9.14%-9.76M-32.75%-17.48M-143.96%-19.78M-15.09%-48.71M43.54%-16.69M
Basic earnings per share 84.51%-0.2274.02%-0.6667.25%-0.94-15.31%-8.509134.51%-1.68915.33%-1.42-20.95%-2.54-139.17%-2.8749.80%-7.379347.47%-2.5793
Diluted earnings per share 84.51%-0.2274.02%-0.6667.25%-0.94-15.31%-8.509134.51%-1.68915.33%-1.42-20.95%-2.54-139.17%-2.8749.80%-7.379347.47%-2.5793
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg